Invention Grant
- Patent Title: KRAS G12C inhibitors and methods of using the same
-
Application No.: US17363878Application Date: 2021-06-30
-
Publication No.: US11766436B2Publication Date: 2023-09-26
- Inventor: John Gordon Allen , Jennifer Rebecca Allen , Ana Elena Minatti , Qiufen Xue , Ryan Paul Wurz , Christopher M. Tegley , Alexander J. Pickrell , Thomas T. Nguyen , Vu Van Ma , Patricia Lopez , Longbin Liu , David John Kopecky , Michael J. Frohn , Ning Chen , Jian Jeffrey Chen , Aaron C. Siegmund , Albert Amegadzie , Nuria A. Tamayo , Shon Booker , Clifford Goodman , Mary Walton , Nobuko Nishimura , Youngsook Shin , Jonathan D. Low , Victor J. Cee , Anthony B. Reed , Hui-Ling Wang , Brian Alan Lanman
- Applicant: Amgen Inc.
- Applicant Address: US CA Thousand Oaks
- Assignee: Amgen Inc.
- Current Assignee: Amgen Inc.
- Current Assignee Address: US CA Thousand Oaks
- Agent Markus Bergauer
- Main IPC: A61K31/517
- IPC: A61K31/517 ; A61P35/00 ; A61K31/4985 ; A61K39/395 ; C07D403/04 ; C07D471/04
Abstract:
Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.
Public/Granted literature
- US20220395504A1 KRAS G12C INHIBITORS AND METHODS OF USING THE SAME Public/Granted day:2022-12-15
Information query
IPC分类:
